Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Endothelin antagonists disclosed by BASF

April 24, 1997

Comparison of aspirin and pentoxifylline for claudication

April 23, 1997

Balanced ETA/ETB antagonist from Abbott

April 22, 1997

Merck KGaA prepares cardioprotective agents

April 22, 1997

PGE1 derivatives for peripheral circulatory disorders from Ono

April 22, 1997

Teva receives FDA approval for antihypertensive generic

April 22, 1997

NitroMed and Cordis collaborate to develop novel cardiovascular products

April 18, 1997

Biovail's Tiazac approved and introduced in Canada

April 17, 1997

Celgene reports dual TNF/PDE inhibitors

April 17, 1997

Defibrillators associated with reduced mortality compared to antiarrhythmic drugs

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...